MS4A1 and familial dilated cardiomyopathy: Moreover, Tschope et al. presented a case series of six patients with subacute and chronic endomyocardial biopsy-confirmed CD20+ B-lymphocyte-associated DCM treated with standard HF therapy in combination with rituximab.